The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pediatric Neuroblastoma Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Pediatric Neuroblastoma Treatment market size is expected to reach US$ 867.1 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Neuroblastoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pediatric Neuroblastoma Treatment market. Immunotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Neuroblastoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Neuroblastoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Neuroblastoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Neuroblastoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Neuroblastoma Treatment covered in this report include United Therapeutics, Apeiron Biologics, Pfizer, Bayer, Baxter, Cellectar Biosciences and MacroGenics, etc.
The global Pediatric Neuroblastoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics
Global Pediatric Neuroblastoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Neuroblastoma Treatment market, Segment by Type:
Immunotherapy
Chemotherapy
Others
Global Pediatric Neuroblastoma Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pediatric Neuroblastoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pediatric Neuroblastoma Treatment market size is expected to reach US$ 867.1 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Neuroblastoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pediatric Neuroblastoma Treatment market. Immunotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Neuroblastoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Neuroblastoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Neuroblastoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Neuroblastoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Neuroblastoma Treatment covered in this report include United Therapeutics, Apeiron Biologics, Pfizer, Bayer, Baxter, Cellectar Biosciences and MacroGenics, etc.
The global Pediatric Neuroblastoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics
Global Pediatric Neuroblastoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Neuroblastoma Treatment market, Segment by Type:
Immunotherapy
Chemotherapy
Others
Global Pediatric Neuroblastoma Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pediatric Neuroblastoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pediatric Neuroblastoma Treatment
1.1 Pediatric Neuroblastoma Treatment Market Overview
1.1.1 Pediatric Neuroblastoma Treatment Product Scope
1.1.2 Pediatric Neuroblastoma Treatment Market Status and Outlook
1.2 Global Pediatric Neuroblastoma Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pediatric Neuroblastoma Treatment Market Size by Region (2018-2029)
1.4 Global Pediatric Neuroblastoma Treatment Historic Market Size by Region (2018-2023)
1.5 Global Pediatric Neuroblastoma Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pediatric Neuroblastoma Treatment Market Size (2018-2029)
1.6.1 North America Pediatric Neuroblastoma Treatment Market Size (2018-2029)
1.6.2 Europe Pediatric Neuroblastoma Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2018-2029)
1.6.4 Latin America Pediatric Neuroblastoma Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2018-2029)
2 Pediatric Neuroblastoma Treatment Market by Type
2.1 Introduction
2.1.1 Immunotherapy
2.1.2 Chemotherapy
2.1.3 Others
2.2 Global Pediatric Neuroblastoma Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pediatric Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pediatric Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pediatric Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
3 Pediatric Neuroblastoma Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pediatric Neuroblastoma Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pediatric Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pediatric Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pediatric Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
4 Pediatric Neuroblastoma Treatment Competition Analysis by Players
4.1 Global Pediatric Neuroblastoma Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2022)
4.3 Date of Key Players Enter into Pediatric Neuroblastoma Treatment Market
4.4 Global Top Players Pediatric Neuroblastoma Treatment Headquarters and Area Served
4.5 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Pediatric Neuroblastoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 United Therapeutics
5.1.1 United Therapeutics Profile
5.1.2 United Therapeutics Main Business
5.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.1.4 United Therapeutics Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 United Therapeutics Recent Developments
5.2 Apeiron Biologics
5.2.1 Apeiron Biologics Profile
5.2.2 Apeiron Biologics Main Business
5.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.2.4 Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Apeiron Biologics Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.3.4 Pfizer Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.4.4 Bayer Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Baxter
5.5.1 Baxter Profile
5.5.2 Baxter Main Business
5.5.3 Baxter Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.5.4 Baxter Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter Recent Developments
5.6 Cellectar Biosciences
5.6.1 Cellectar Biosciences Profile
5.6.2 Cellectar Biosciences Main Business
5.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.6.4 Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Cellectar Biosciences Recent Developments
5.7 MacroGenics
5.7.1 MacroGenics Profile
5.7.2 MacroGenics Main Business
5.7.3 MacroGenics Pediatric Neuroblastoma Treatment Products, Services and Solutions
5.7.4 MacroGenics Pediatric Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 MacroGenics Recent Developments
6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pediatric Neuroblastoma Treatment Market Dynamics
11.1 Pediatric Neuroblastoma Treatment Industry Trends
11.2 Pediatric Neuroblastoma Treatment Market Drivers
11.3 Pediatric Neuroblastoma Treatment Market Challenges
11.4 Pediatric Neuroblastoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
